Search Results

There are 61026 results for: content related to: Efficacy and tolerance of interferon-α in the treatment of chronic Hepatitis C in end-stage renal disease patients on hemodialysis

  1. Consensus interferon and ribavirin for patients with chronic hepatitis C and failure of previous interferon-α therapy

    Liver International

    Volume 26, Issue 3, April 2006, Pages: 319–325, Wulf O. Böcher, Marcus Schuchmann, Ralph Link, Heribert Hillenbrand, Fareed Rahman, Martin Sprinzl, Jonas Mudter, Hanns F. Löhr and Peter R. Galle

    Version of Record online : 10 FEB 2006, DOI: 10.1111/j.1478-3231.2005.01239.x

  2. Relapse to prior therapy is the most important factor for the retreatment response in patients with chronic hepatitis C virus infection

    Liver International

    Volume 27, Issue 7, September 2007, Pages: 954–959, Abdurrahman Sagir, Tobias Heintges, Zübeyde Akyazi, Mark Oette, Andreas Erhardt and Dieter Häussinger

    Version of Record online : 5 JUN 2007, DOI: 10.1111/j.1478-3231.2007.01508.x

  3. γ-Glutamyltransferase and rapid virological response as predictors of successful treatment with experimental or standard peginterferon-α-2b in chronic hepatitis C non-responders

    Liver International

    Volume 27, Issue 9, November 2007, Pages: 1217–1225, Jilling F. Bergmann, Jan M. Vrolijk, Peter Van Der Schaar, Brigitte Vroom, Bart Van Hoek, Annet Van Der Sluys Veer, Richard A. De Vries, Elke Verhey, Bettina E. Hansen, Johannes T. Brouwer, Harry L. A. Janssen, Solko W. Schalm and Robert J. De Knegt

    Version of Record online : 15 AUG 2007, DOI: 10.1111/j.1478-3231.2007.01540.x

  4. You have free access to this content
    Hepatitis C virus genotype 4 therapy: progress and challenges

    Liver International

    Volume 31, Issue s1, January 2011, Pages: 45–52, Sanaa M. Kamal

    Version of Record online : 4 JAN 2011, DOI: 10.1111/j.1478-3231.2010.02385.x

  5. You have free access to this content
    Hepatitis C genotype 4 therapy: increasing options and improving outcomes

    Liver International

    Volume 29, Issue s1, January 2009, Pages: 39–48, Sanaa M. Kamal

    Version of Record online : 21 JAN 2009, DOI: 10.1111/j.1478-3231.2008.01930.x

  6. Treatment and retreatment in patients with chronic hepatitis C: 10 years clinical practice in a single centre

    Liver International

    Volume 27, Issue 3, April 2007, Pages: 340–346, Michael S. Economou, Spyridon Filis, Helen Vienna, Dimitrios Christodoulou, Leonidas Christou and Epameinondas V. Tsianos

    Version of Record online : 8 FEB 2007, DOI: 10.1111/j.1478-3231.2006.01437.x

  7. You have free access to this content
    Treatment of HBeAg-negative chronic hepatitis B patients with nucleos(t)ide analogues

    Liver International

    Volume 31, Issue s1, January 2011, Pages: 95–103, George V. Papatheodoridis

    Version of Record online : 4 JAN 2011, DOI: 10.1111/j.1478-3231.2010.02392.x

    Corrected by:

    ERRATA

    Vol. 31, Issue 5, 748, Version of Record online: 22 MAR 2011

  8. Enhanced efficacy of pegylated interferon alpha-2a over pegylated interferon and ribavirin in chronic hepatitis C genotype 4A randomized trial and quality of life analysis

    Liver International

    Volume 31, Issue 3, March 2011, Pages: 401–411, Sanaa M. Kamal, Amany Ahmed, Sara Mahmoud, Leila Nabegh, Iman El Gohary, Isi Obadan, Tamer Hafez, Dahlia Ghoraba, Ahmed A. Aziz and Mona Metaoei

    Version of Record online : 11 JAN 2011, DOI: 10.1111/j.1478-3231.2010.02435.x

    Corrected by:

    CORRIGENDA

    Vol. 31, Issue 4, 588, Version of Record online: 17 FEB 2011

  9. Growth inhibitory effects of pegylated IFN α-2b on human liver cancer cells in vitro and in vivo

    Liver International

    Volume 26, Issue 8, October 2006, Pages: 964–975, Hirohisa Yano, Sachiko Ogasawara, Seiya Momosaki, Jun Akiba, Sakiko Kojiro, Suguru Fukahori, Hironori Ishizaki, Keitaro Kuratomi, Yuji Basaki, Shinji Oie, Michihiko Kuwano and Masamichi Kojiro

    Version of Record online : 10 AUG 2006, DOI: 10.1111/j.1478-3231.2006.01321.x

  10. High incidence of type 1 diabetes mellitus during or shortly after treatment with pegylated interferon α for chronic hepatitis C virus infection

    Liver International

    Volume 28, Issue 1, January 2008, Pages: 39–46, Tim C. M. A. Schreuder, Huub C. Gelderblom, Christine J. Weegink, Dörte Hamann, Henk W. Reesink, J. Hans DeVries, Joost B. L. Hoekstra and Peter L. M. Jansen

    Version of Record online : 21 NOV 2007, DOI: 10.1111/j.1478-3231.2007.01610.x

  11. You have full text access to this OnlineOpen article
    Managing chronic hepatitis C in the difficult-to-treat patient

    Liver International

    Volume 27, Issue 10, December 2007, Pages: 1297–1310, Nyingi Kemmer and Guy W. Neff

    Version of Record online : 20 NOV 2007, DOI: 10.1111/j.1478-3231.2007.01613.x

  12. Incidence of psychiatric side effects during pegylated interferon- α retreatment in nonresponder hepatitis C virus-infected patients

    Liver International

    Volume 27, Issue 8, October 2007, Pages: 1098–1102, Lucas C. Quarantini, Rodrigo A. Bressan, Amanda Galvão, Susana Batista-Neves, Raymundo Paraná and Ângela Miranda-Scippa

    Version of Record online : 16 AUG 2007, DOI: 10.1111/j.1478-3231.2007.01532.x

  13. You have free access to this content
    The neglected hepatitis C virus genotypes 4, 5 and 6: an international consensus report

    Liver International

    Volume 30, Issue 3, March 2010, Pages: 342–355, Nabil Antaki, Antonio Craxi, Sanaa Kamal, Rami Moucari, Schalk Van der Merwe, Samir Haffar, Adrian Gadano, Nizar Zein, Ching Lung Lai, Jean-Michel Pawlotsky, E. Jenny Heathcote, Geoffrey Dusheiko and Patrick Marcellin

    Version of Record online : 10 DEC 2009, DOI: 10.1111/j.1478-3231.2009.02188.x

  14. Anemia associated with antiviral therapy in chronic hepatitis C: incidence, risk factors, and impact on treatment response

    Liver International

    Volume 26, Issue 9, November 2006, Pages: 1079–1086, Chao-Hung Hung, Chuan-Mo Lee, Sheng-Nan Lu, Jing-Houng Wang, Chien-Hung Chen, Tsung-Hui Hu, Kwong-Ming Kee, Kuo-Chin Chang, Po-Lin Tseng, Yi-Hao Yen and Chi-Sin Changchien

    Version of Record online : 10 OCT 2006, DOI: 10.1111/j.1478-3231.2006.01354.x

  15. Liver cell lines for the study of hepatocyte functions and immunological response

    Liver International

    Volume 25, Issue 2, April 2005, Pages: 389–402, Reginald F. Clayton, Angela Rinaldi, Eve E. Kandyba, Mike Edward, Christian Willberg, Paul Klenerman and Arvind H. Patel

    Version of Record online : 17 MAR 2005, DOI: 10.1111/j.1478-3231.2005.01017.x

  16. You have free access to this content
    2011 European Association of the Study of the Liver hepatitis C virus clinical practice guidelines

    Liver International

    Volume 32, Issue s1, February 2012, Pages: 2–8, Vincenza Calvaruso and Antonio Craxì

    Version of Record online : 29 DEC 2011, DOI: 10.1111/j.1478-3231.2011.02703.x

  17. You have free access to this content
    Retreatment of chronic hepatitis C: who and how?

    Liver International

    Volume 29, Issue s1, January 2009, Pages: 49–56, Jenny Heathcote

    Version of Record online : 21 JAN 2009, DOI: 10.1111/j.1478-3231.2008.01932.x

  18. Successful treatment of hepatitis C reinfection with interferon-α2b and ribavirin after liver transplantation

    Liver International

    Volume 25, Issue 4, August 2005, Pages: 717–722, Süleyman Yedibela, Detlef Schuppan, Volker Müller, Vera Schellerer, Andrea Tannapfel, Werner Hohenberger and Thomas Meyer

    Version of Record online : 21 APR 2005, DOI: 10.1111/j.1478-3231.2005.1065.x

  19. Hepatitis C

    Standard Article

    Wiley Handbook of Current and Emerging Drug Therapies

    Published Online : 15 SEP 2006, DOI: 10.1002/9780470041000.cedt033

  20. You have free access to this content
    Hepatitis D virus: an update

    Liver International

    Volume 31, Issue 1, January 2011, Pages: 7–21, Stéphanie Pascarella and Francesco Negro

    Version of Record online : 28 SEP 2010, DOI: 10.1111/j.1478-3231.2010.02320.x